Qvar is an inhaled corticosteroid medication used for the maintenance treatment of asthma in adults. The active ingredient ciclesonide is a lipophilic prodrug that undergoes enzymatic activation within the lung tissue to form the pharmacologically active glucocorticoid. Once metabolized it binds with high affinity to intracellular glucocorticoid receptors, modulating gene expression pathways that regulate inflammatory processes. This interaction suppresses the transcription of cytokines and chemokines such as interleukin-4 and interleukin-13, thereby reducing airway inflammation. The drug is delivered via a metered dose inhaler that provides a fine particle aerosol allowing deep lung deposition. After deposition the active metabolite exerts its pharmacologic effect locally while systemic exposure remains low due to extensive first-pass metabolism. Its high potency and long duration of action enable sustained control of airway inflammation with once-daily dosing. The overall therapeutic role of Qvar is to provide anti-inflammatory control of chronic respiratory disease without requiring systemic administration.

Qvar is an inhaled corticosteroid medication used to help control asthma symptoms. It works by delivering the drug directly to the lungs where it reduces inflammation. The active ingredient, beclomethasone dipropionate, binds to glucocorticoid receptors in lung cells. This binding triggers the release of proteins that calm an overactive immune response. As a result, the airways stay open longer and breathing becomes easier during daily activities. Qvar provides long-lasting control of asthma by maintaining a steady reduction of airway swelling.

Some patients experience mild throat irritation after using Qvar. Occasional hoarseness may occur due to the medication's local effect on the airway. Dry cough is another frequently reported symptom. Mild oral fungal infections such as thrush can develop if the inhaler is not rinsed after use. Headache and nasal irritation are also documented common reactions. Some users notice a slight change in taste or a metallic sensation after inhalation. These side effects are generally transient and do not require intervention beyond routine monitoring.

Qvar may cause a sore throat or throat irritation in some patients. It can also lead to hoarseness or voice changes after inhalation. Some individuals experience coughing or mild respiratory discomfort. Occasional dry mouth or oral irritation has been reported. Headache and nasopharyngitis are among the frequently observed side effects. These reactions are generally mild and often resolve with continued use.